nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertindole—CYP2D6—Methimazole—Graves' disease	0.512	0.611	CbGbCtD
Sertindole—CYP3A4—Methimazole—Graves' disease	0.325	0.389	CbGbCtD
Sertindole—HTR1A—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00353	0.0216	CbGpPWpGaD
Sertindole—HTR2C—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00351	0.0215	CbGpPWpGaD
Sertindole—ADRA1B—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00336	0.0206	CbGpPWpGaD
Sertindole—DRD2—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.0031	0.019	CbGpPWpGaD
Sertindole—HTR2A—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00305	0.0187	CbGpPWpGaD
Sertindole—HRH1—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00304	0.0187	CbGpPWpGaD
Sertindole—ADRA1A—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00298	0.0183	CbGpPWpGaD
Sertindole—ADRA2A—GPCRs, Class A Rhodopsin-like—GPR174—Graves' disease	0.00277	0.017	CbGpPWpGaD
Sertindole—HTR6—G alpha (s) signalling events—TSHR—Graves' disease	0.00182	0.0112	CbGpPWpGaD
Sertindole—KCNH2—Neuronal System—GABRA3—Graves' disease	0.00166	0.0102	CbGpPWpGaD
Sertindole—SLC6A4—Monoamine Transport—IL1B—Graves' disease	0.00166	0.0102	CbGpPWpGaD
Sertindole—KCNH2—Hematopoietic Stem Cell Differentiation—IL1B—Graves' disease	0.00154	0.00947	CbGpPWpGaD
Sertindole—HTR1F—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.00135	0.00826	CbGpPWpGaD
Sertindole—HTR1E—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.00127	0.0078	CbGpPWpGaD
Sertindole—SLC6A4—Monoamine Transport—TNF—Graves' disease	0.00121	0.0074	CbGpPWpGaD
Sertindole—HTR1F—G alpha (i) signalling events—CXCL10—Graves' disease	0.00109	0.00672	CbGpPWpGaD
Sertindole—HTR1E—G alpha (i) signalling events—CXCL10—Graves' disease	0.00103	0.00634	CbGpPWpGaD
Sertindole—HTR1F—GPCR ligand binding—TSHR—Graves' disease	0.00103	0.00629	CbGpPWpGaD
Sertindole—HTR1E—GPCR ligand binding—TSHR—Graves' disease	0.000967	0.00594	CbGpPWpGaD
Sertindole—HTR1F—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.00087	0.00534	CbGpPWpGaD
Sertindole—HTR6—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000868	0.00533	CbGpPWpGaD
Sertindole—HTR1D—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000861	0.00528	CbGpPWpGaD
Sertindole—HTR1B—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000843	0.00517	CbGpPWpGaD
Sertindole—DRD4—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.00083	0.00509	CbGpPWpGaD
Sertindole—HTR1E—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000821	0.00504	CbGpPWpGaD
Sertindole—ADRA1D—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000737	0.00452	CbGpPWpGaD
Sertindole—DRD3—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000737	0.00452	CbGpPWpGaD
Sertindole—HTR1D—G alpha (i) signalling events—CXCL10—Graves' disease	0.0007	0.00429	CbGpPWpGaD
Sertindole—HTR1B—G alpha (i) signalling events—CXCL10—Graves' disease	0.000685	0.00421	CbGpPWpGaD
Sertindole—DRD4—G alpha (i) signalling events—CXCL10—Graves' disease	0.000674	0.00414	CbGpPWpGaD
Sertindole—HTR1F—GPCR ligand binding—CXCL10—Graves' disease	0.000663	0.00407	CbGpPWpGaD
Sertindole—HTR6—GPCR ligand binding—TSHR—Graves' disease	0.000661	0.00406	CbGpPWpGaD
Sertindole—HTR1D—GPCR ligand binding—TSHR—Graves' disease	0.000656	0.00402	CbGpPWpGaD
Sertindole—SLC6A4—Circadian rythm related genes—FAS—Graves' disease	0.000653	0.00401	CbGpPWpGaD
Sertindole—HTR1A—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000642	0.00394	CbGpPWpGaD
Sertindole—HTR1B—GPCR ligand binding—TSHR—Graves' disease	0.000642	0.00394	CbGpPWpGaD
Sertindole—HTR2C—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000639	0.00392	CbGpPWpGaD
Sertindole—DRD4—GPCR ligand binding—TSHR—Graves' disease	0.000632	0.00388	CbGpPWpGaD
Sertindole—HTR1E—GPCR ligand binding—CXCL10—Graves' disease	0.000625	0.00384	CbGpPWpGaD
Sertindole—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000612	0.00375	CbGpPWpGaD
Sertindole—DRD3—G alpha (i) signalling events—CXCL10—Graves' disease	0.000599	0.00368	CbGpPWpGaD
Sertindole—DRD4—Circadian rythm related genes—FAS—Graves' disease	0.000587	0.0036	CbGpPWpGaD
Sertindole—HTR1F—GPCR downstream signaling—TSHR—Graves' disease	0.00058	0.00356	CbGpPWpGaD
Sertindole—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000564	0.00346	CbGpPWpGaD
Sertindole—DRD3—GPCR ligand binding—TSHR—Graves' disease	0.000561	0.00344	CbGpPWpGaD
Sertindole—ADRA1D—GPCR ligand binding—TSHR—Graves' disease	0.000561	0.00344	CbGpPWpGaD
Sertindole—HTR6—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000561	0.00344	CbGpPWpGaD
Sertindole—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000556	0.00341	CbGpPWpGaD
Sertindole—HTR2A—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000555	0.00341	CbGpPWpGaD
Sertindole—HRH1—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000554	0.0034	CbGpPWpGaD
Sertindole—HTR1E—GPCR downstream signaling—TSHR—Graves' disease	0.000547	0.00335	CbGpPWpGaD
Sertindole—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000545	0.00334	CbGpPWpGaD
Sertindole—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000543	0.00333	CbGpPWpGaD
Sertindole—DRD4—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000536	0.00329	CbGpPWpGaD
Sertindole—HTR1F—Signaling by GPCR—TSHR—Graves' disease	0.000526	0.00323	CbGpPWpGaD
Sertindole—HTR1A—G alpha (i) signalling events—CXCL10—Graves' disease	0.000522	0.0032	CbGpPWpGaD
Sertindole—DRD3—Circadian rythm related genes—FAS—Graves' disease	0.000522	0.0032	CbGpPWpGaD
Sertindole—KCNH2—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.00052	0.00319	CbGpPWpGaD
Sertindole—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000505	0.0031	CbGpPWpGaD
Sertindole—HTR1E—Signaling by GPCR—TSHR—Graves' disease	0.000496	0.00305	CbGpPWpGaD
Sertindole—HTR1A—GPCR ligand binding—TSHR—Graves' disease	0.000489	0.003	CbGpPWpGaD
Sertindole—HTR2C—GPCR ligand binding—TSHR—Graves' disease	0.000487	0.00299	CbGpPWpGaD
Sertindole—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000476	0.00292	CbGpPWpGaD
Sertindole—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000476	0.00292	CbGpPWpGaD
Sertindole—SLC6A4—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000468	0.00287	CbGpPWpGaD
Sertindole—ADRA1B—GPCR ligand binding—TSHR—Graves' disease	0.000466	0.00286	CbGpPWpGaD
Sertindole—DRD2—G alpha (i) signalling events—CXCL10—Graves' disease	0.000458	0.00281	CbGpPWpGaD
Sertindole—DRD2—GPCR ligand binding—TSHR—Graves' disease	0.000429	0.00264	CbGpPWpGaD
Sertindole—HTR6—GPCR ligand binding—CXCL10—Graves' disease	0.000427	0.00262	CbGpPWpGaD
Sertindole—HTR1D—GPCR ligand binding—CXCL10—Graves' disease	0.000424	0.0026	CbGpPWpGaD
Sertindole—HTR2A—GPCR ligand binding—TSHR—Graves' disease	0.000423	0.00259	CbGpPWpGaD
Sertindole—HRH1—GPCR ligand binding—TSHR—Graves' disease	0.000422	0.00259	CbGpPWpGaD
Sertindole—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000415	0.00255	CbGpPWpGaD
Sertindole—HTR1B—GPCR ligand binding—CXCL10—Graves' disease	0.000415	0.00255	CbGpPWpGaD
Sertindole—ADRA1A—GPCR ligand binding—TSHR—Graves' disease	0.000414	0.00254	CbGpPWpGaD
Sertindole—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000413	0.00253	CbGpPWpGaD
Sertindole—ADRA2A—G alpha (i) signalling events—CXCL10—Graves' disease	0.00041	0.00252	CbGpPWpGaD
Sertindole—DRD4—GPCR ligand binding—CXCL10—Graves' disease	0.000408	0.00251	CbGpPWpGaD
Sertindole—DRD2—Circadian rythm related genes—FAS—Graves' disease	0.000399	0.00245	CbGpPWpGaD
Sertindole—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000395	0.00243	CbGpPWpGaD
Sertindole—ADRA2A—GPCR ligand binding—TSHR—Graves' disease	0.000384	0.00236	CbGpPWpGaD
Sertindole—KCNH2—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000377	0.00231	CbGpPWpGaD
Sertindole—HTR1F—GPCR downstream signaling—CXCL10—Graves' disease	0.000374	0.0023	CbGpPWpGaD
Sertindole—HTR6—GPCR downstream signaling—TSHR—Graves' disease	0.000373	0.00229	CbGpPWpGaD
Sertindole—HTR1D—GPCR downstream signaling—TSHR—Graves' disease	0.000371	0.00227	CbGpPWpGaD
Sertindole—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000364	0.00224	CbGpPWpGaD
Sertindole—HTR1B—GPCR downstream signaling—TSHR—Graves' disease	0.000363	0.00223	CbGpPWpGaD
Sertindole—DRD3—GPCR ligand binding—CXCL10—Graves' disease	0.000363	0.00223	CbGpPWpGaD
Sertindole—ADRA1D—GPCR ligand binding—CXCL10—Graves' disease	0.000363	0.00223	CbGpPWpGaD
Sertindole—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000359	0.0022	CbGpPWpGaD
Sertindole—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000358	0.0022	CbGpPWpGaD
Sertindole—DRD4—GPCR downstream signaling—TSHR—Graves' disease	0.000357	0.00219	CbGpPWpGaD
Sertindole—HTR1E—GPCR downstream signaling—CXCL10—Graves' disease	0.000353	0.00217	CbGpPWpGaD
Sertindole—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000351	0.00215	CbGpPWpGaD
Sertindole—HTR1F—Signaling by GPCR—CXCL10—Graves' disease	0.00034	0.00209	CbGpPWpGaD
Sertindole—SLC6A4—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000339	0.00208	CbGpPWpGaD
Sertindole—HTR6—Signaling by GPCR—TSHR—Graves' disease	0.000339	0.00208	CbGpPWpGaD
Sertindole—HTR1D—Signaling by GPCR—TSHR—Graves' disease	0.000337	0.00207	CbGpPWpGaD
Sertindole—HTR1B—Signaling by GPCR—TSHR—Graves' disease	0.00033	0.00202	CbGpPWpGaD
Sertindole—ADRA2A—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000329	0.00202	CbGpPWpGaD
Sertindole—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000326	0.002	CbGpPWpGaD
Sertindole—HTR1A—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000326	0.002	CbGpPWpGaD
Sertindole—DRD4—Signaling by GPCR—TSHR—Graves' disease	0.000324	0.00199	CbGpPWpGaD
Sertindole—HTR1E—Signaling by GPCR—CXCL10—Graves' disease	0.000321	0.00197	CbGpPWpGaD
Sertindole—ADRA1D—GPCR downstream signaling—TSHR—Graves' disease	0.000317	0.00195	CbGpPWpGaD
Sertindole—DRD3—GPCR downstream signaling—TSHR—Graves' disease	0.000317	0.00195	CbGpPWpGaD
Sertindole—HTR1A—GPCR ligand binding—CXCL10—Graves' disease	0.000316	0.00194	CbGpPWpGaD
Sertindole—HTR2C—GPCR ligand binding—CXCL10—Graves' disease	0.000314	0.00193	CbGpPWpGaD
Sertindole—HTR1F—Signaling Pathways—TSHR—Graves' disease	0.000311	0.00191	CbGpPWpGaD
Sertindole—ADRA1B—GPCR ligand binding—CXCL10—Graves' disease	0.000301	0.00185	CbGpPWpGaD
Sertindole—HTR1E—Signaling Pathways—TSHR—Graves' disease	0.000293	0.0018	CbGpPWpGaD
Sertindole—DRD3—Signaling by GPCR—TSHR—Graves' disease	0.000288	0.00177	CbGpPWpGaD
Sertindole—ADRA1D—Signaling by GPCR—TSHR—Graves' disease	0.000288	0.00177	CbGpPWpGaD
Sertindole—HTR1F—GPCR downstream signaling—IL2RA—Graves' disease	0.000286	0.00176	CbGpPWpGaD
Sertindole—HTR2A—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000282	0.00173	CbGpPWpGaD
Sertindole—DRD2—GPCR ligand binding—CXCL10—Graves' disease	0.000278	0.0017	CbGpPWpGaD
Sertindole—HTR1A—GPCR downstream signaling—TSHR—Graves' disease	0.000276	0.0017	CbGpPWpGaD
Sertindole—HTR2C—GPCR downstream signaling—TSHR—Graves' disease	0.000275	0.00169	CbGpPWpGaD
Sertindole—HTR2A—GPCR ligand binding—CXCL10—Graves' disease	0.000273	0.00168	CbGpPWpGaD
Sertindole—HRH1—GPCR ligand binding—CXCL10—Graves' disease	0.000272	0.00167	CbGpPWpGaD
Sertindole—HTR1E—GPCR downstream signaling—IL2RA—Graves' disease	0.00027	0.00166	CbGpPWpGaD
Sertindole—ADRA1A—GPCR ligand binding—CXCL10—Graves' disease	0.000267	0.00164	CbGpPWpGaD
Sertindole—ADRA1B—GPCR downstream signaling—TSHR—Graves' disease	0.000263	0.00162	CbGpPWpGaD
Sertindole—HTR1F—Signaling by GPCR—IL2RA—Graves' disease	0.00026	0.00159	CbGpPWpGaD
Sertindole—HTR1A—Signaling by GPCR—TSHR—Graves' disease	0.000251	0.00154	CbGpPWpGaD
Sertindole—HTR2C—Signaling by GPCR—TSHR—Graves' disease	0.00025	0.00153	CbGpPWpGaD
Sertindole—ADRA2A—GPCR ligand binding—CXCL10—Graves' disease	0.000248	0.00152	CbGpPWpGaD
Sertindole—HTR1E—Signaling by GPCR—IL2RA—Graves' disease	0.000245	0.0015	CbGpPWpGaD
Sertindole—DRD2—GPCR downstream signaling—TSHR—Graves' disease	0.000243	0.00149	CbGpPWpGaD
Sertindole—HTR6—GPCR downstream signaling—CXCL10—Graves' disease	0.000241	0.00148	CbGpPWpGaD
Sertindole—HTR1D—GPCR downstream signaling—CXCL10—Graves' disease	0.000239	0.00147	CbGpPWpGaD
Sertindole—ADRA1B—Signaling by GPCR—TSHR—Graves' disease	0.000239	0.00147	CbGpPWpGaD
Sertindole—HTR2A—GPCR downstream signaling—TSHR—Graves' disease	0.000239	0.00147	CbGpPWpGaD
Sertindole—HRH1—GPCR downstream signaling—TSHR—Graves' disease	0.000238	0.00146	CbGpPWpGaD
Sertindole—HTR1A—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000236	0.00145	CbGpPWpGaD
Sertindole—HTR1B—GPCR downstream signaling—CXCL10—Graves' disease	0.000234	0.00144	CbGpPWpGaD
Sertindole—ADRA1A—GPCR downstream signaling—TSHR—Graves' disease	0.000234	0.00143	CbGpPWpGaD
Sertindole—DRD4—GPCR downstream signaling—CXCL10—Graves' disease	0.000231	0.00142	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—GC—Graves' disease	0.000222	0.00136	CbGpPWpGaD
Sertindole—DRD2—Signaling by GPCR—TSHR—Graves' disease	0.00022	0.00135	CbGpPWpGaD
Sertindole—HTR6—Signaling by GPCR—CXCL10—Graves' disease	0.000219	0.00134	CbGpPWpGaD
Sertindole—HTR1D—Signaling by GPCR—CXCL10—Graves' disease	0.000217	0.00133	CbGpPWpGaD
Sertindole—ADRA2A—GPCR downstream signaling—TSHR—Graves' disease	0.000217	0.00133	CbGpPWpGaD
Sertindole—HTR2A—Signaling by GPCR—TSHR—Graves' disease	0.000217	0.00133	CbGpPWpGaD
Sertindole—HRH1—Signaling by GPCR—TSHR—Graves' disease	0.000216	0.00133	CbGpPWpGaD
Sertindole—HTR1B—Signaling by GPCR—CXCL10—Graves' disease	0.000213	0.00131	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—TSHR—Graves' disease	0.000212	0.0013	CbGpPWpGaD
Sertindole—DRD4—Signaling by GPCR—CXCL10—Graves' disease	0.00021	0.00129	CbGpPWpGaD
Sertindole—ADRA1D—GPCR downstream signaling—CXCL10—Graves' disease	0.000205	0.00126	CbGpPWpGaD
Sertindole—DRD3—GPCR downstream signaling—CXCL10—Graves' disease	0.000205	0.00126	CbGpPWpGaD
Sertindole—HTR2A—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000204	0.00125	CbGpPWpGaD
Sertindole—HTR1F—Signaling Pathways—CXCL10—Graves' disease	0.000201	0.00123	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—TSHR—Graves' disease	0.0002	0.00123	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—TSHR—Graves' disease	0.000199	0.00122	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—TSHR—Graves' disease	0.000197	0.00121	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—TSHR—Graves' disease	0.000195	0.00119	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—TSHR—Graves' disease	0.000192	0.00118	CbGpPWpGaD
Sertindole—HTR1E—Signaling Pathways—CXCL10—Graves' disease	0.00019	0.00116	CbGpPWpGaD
Sertindole—ADRA1D—Signaling by GPCR—CXCL10—Graves' disease	0.000186	0.00114	CbGpPWpGaD
Sertindole—DRD3—Signaling by GPCR—CXCL10—Graves' disease	0.000186	0.00114	CbGpPWpGaD
Sertindole—HTR6—GPCR downstream signaling—IL2RA—Graves' disease	0.000184	0.00113	CbGpPWpGaD
Sertindole—HTR1D—GPCR downstream signaling—IL2RA—Graves' disease	0.000183	0.00112	CbGpPWpGaD
Sertindole—HTR1B—GPCR downstream signaling—IL2RA—Graves' disease	0.000179	0.0011	CbGpPWpGaD
Sertindole—HTR1A—GPCR downstream signaling—CXCL10—Graves' disease	0.000179	0.0011	CbGpPWpGaD
Sertindole—HTR2C—GPCR downstream signaling—CXCL10—Graves' disease	0.000178	0.00109	CbGpPWpGaD
Sertindole—DRD4—GPCR downstream signaling—IL2RA—Graves' disease	0.000176	0.00108	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—TSHR—Graves' disease	0.00017	0.00104	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—TSHR—Graves' disease	0.00017	0.00104	CbGpPWpGaD
Sertindole—ADRA1B—GPCR downstream signaling—CXCL10—Graves' disease	0.00017	0.00104	CbGpPWpGaD
Sertindole—ADRA2A—Hemostasis—IL2RA—Graves' disease	0.00017	0.00104	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—B3GNT2—Graves' disease	0.000168	0.00103	CbGpPWpGaD
Sertindole—HTR6—Signaling by GPCR—IL2RA—Graves' disease	0.000167	0.00103	CbGpPWpGaD
Sertindole—HTR1D—Signaling by GPCR—IL2RA—Graves' disease	0.000166	0.00102	CbGpPWpGaD
Sertindole—HTR1B—Signaling by GPCR—IL2RA—Graves' disease	0.000163	0.000999	CbGpPWpGaD
Sertindole—HTR1A—Signaling by GPCR—CXCL10—Graves' disease	0.000162	0.000995	CbGpPWpGaD
Sertindole—HTR2C—Signaling by GPCR—CXCL10—Graves' disease	0.000161	0.00099	CbGpPWpGaD
Sertindole—DRD4—Signaling by GPCR—IL2RA—Graves' disease	0.00016	0.000983	CbGpPWpGaD
Sertindole—DRD2—GPCR downstream signaling—CXCL10—Graves' disease	0.000157	0.000962	CbGpPWpGaD
Sertindole—ADRA1D—GPCR downstream signaling—IL2RA—Graves' disease	0.000157	0.000961	CbGpPWpGaD
Sertindole—DRD3—GPCR downstream signaling—IL2RA—Graves' disease	0.000157	0.000961	CbGpPWpGaD
Sertindole—ADRA1B—Signaling by GPCR—CXCL10—Graves' disease	0.000154	0.000948	CbGpPWpGaD
Sertindole—HTR2A—GPCR downstream signaling—CXCL10—Graves' disease	0.000154	0.000947	CbGpPWpGaD
Sertindole—HRH1—GPCR downstream signaling—CXCL10—Graves' disease	0.000154	0.000945	CbGpPWpGaD
Sertindole—HTR1F—Signaling Pathways—IL2RA—Graves' disease	0.000154	0.000942	CbGpPWpGaD
Sertindole—ADRA1A—GPCR downstream signaling—CXCL10—Graves' disease	0.000151	0.000927	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—TSHR—Graves' disease	0.000148	0.00091	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—TSHR—Graves' disease	0.000148	0.000905	CbGpPWpGaD
Sertindole—HTR1E—Signaling Pathways—IL2RA—Graves' disease	0.000145	0.000889	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—GC—Graves' disease	0.000145	0.000888	CbGpPWpGaD
Sertindole—DRD2—Signaling by GPCR—CXCL10—Graves' disease	0.000142	0.000874	CbGpPWpGaD
Sertindole—ADRA1D—Signaling by GPCR—IL2RA—Graves' disease	0.000142	0.000873	CbGpPWpGaD
Sertindole—DRD3—Signaling by GPCR—IL2RA—Graves' disease	0.000142	0.000873	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—TSHR—Graves' disease	0.000141	0.000867	CbGpPWpGaD
Sertindole—ADRA2A—GPCR downstream signaling—CXCL10—Graves' disease	0.00014	0.000862	CbGpPWpGaD
Sertindole—HTR2A—Signaling by GPCR—CXCL10—Graves' disease	0.00014	0.00086	CbGpPWpGaD
Sertindole—HRH1—Signaling by GPCR—CXCL10—Graves' disease	0.00014	0.000858	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—CXCL10—Graves' disease	0.000137	0.000842	CbGpPWpGaD
Sertindole—HTR1A—GPCR downstream signaling—IL2RA—Graves' disease	0.000137	0.000838	CbGpPWpGaD
Sertindole—HTR2C—GPCR downstream signaling—IL2RA—Graves' disease	0.000136	0.000833	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—TSHR—Graves' disease	0.00013	0.000799	CbGpPWpGaD
Sertindole—ADRA1B—GPCR downstream signaling—IL2RA—Graves' disease	0.00013	0.000798	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—CXCL10—Graves' disease	0.000129	0.000794	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—CXCL10—Graves' disease	0.000128	0.000788	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—TSHR—Graves' disease	0.000128	0.000786	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—TSHR—Graves' disease	0.000128	0.000784	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—CXCL10—Graves' disease	0.000127	0.000782	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—CXCL10—Graves' disease	0.000126	0.000772	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—TSHR—Graves' disease	0.000125	0.00077	CbGpPWpGaD
Sertindole—HTR1A—Signaling by GPCR—IL2RA—Graves' disease	0.000124	0.000761	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—CXCL10—Graves' disease	0.000124	0.00076	CbGpPWpGaD
Sertindole—HTR2C—Signaling by GPCR—IL2RA—Graves' disease	0.000123	0.000757	CbGpPWpGaD
Sertindole—DRD2—GPCR downstream signaling—IL2RA—Graves' disease	0.00012	0.000736	CbGpPWpGaD
Sertindole—ADRA1B—Signaling by GPCR—IL2RA—Graves' disease	0.000118	0.000725	CbGpPWpGaD
Sertindole—HTR2A—GPCR downstream signaling—IL2RA—Graves' disease	0.000118	0.000724	CbGpPWpGaD
Sertindole—HRH1—GPCR downstream signaling—IL2RA—Graves' disease	0.000118	0.000722	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—TSHR—Graves' disease	0.000117	0.000715	CbGpPWpGaD
Sertindole—ADRA1A—GPCR downstream signaling—IL2RA—Graves' disease	0.000115	0.000709	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—CXCL10—Graves' disease	0.00011	0.000675	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—CXCL10—Graves' disease	0.00011	0.000675	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—B3GNT2—Graves' disease	0.00011	0.000673	CbGpPWpGaD
Sertindole—DRD2—Signaling by GPCR—IL2RA—Graves' disease	0.000109	0.000668	CbGpPWpGaD
Sertindole—ADRA2A—GPCR downstream signaling—IL2RA—Graves' disease	0.000107	0.000658	CbGpPWpGaD
Sertindole—HTR2A—Signaling by GPCR—IL2RA—Graves' disease	0.000107	0.000657	CbGpPWpGaD
Sertindole—HRH1—Signaling by GPCR—IL2RA—Graves' disease	0.000107	0.000656	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—IL2RA—Graves' disease	0.000105	0.000644	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—IL2RA—Graves' disease	9.89e-05	0.000607	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—IL2RA—Graves' disease	9.82e-05	0.000603	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—IL2RA—Graves' disease	9.74e-05	0.000598	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—IL2RA—Graves' disease	9.61e-05	0.00059	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—CXCL10—Graves' disease	9.58e-05	0.000588	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—CXCL10—Graves' disease	9.53e-05	0.000585	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—IL2RA—Graves' disease	9.46e-05	0.000581	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—GC—Graves' disease	9.46e-05	0.00058	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—CXCL10—Graves' disease	9.13e-05	0.00056	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—CXCL10—Graves' disease	8.41e-05	0.000516	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—IL2RA—Graves' disease	8.4e-05	0.000516	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—IL2RA—Graves' disease	8.4e-05	0.000516	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—CXCL10—Graves' disease	8.28e-05	0.000508	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—CXCL10—Graves' disease	8.26e-05	0.000507	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—CXCL10—Graves' disease	8.11e-05	0.000497	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—CXCL10—Graves' disease	7.53e-05	0.000462	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—IL2RA—Graves' disease	7.32e-05	0.000449	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—IL2RA—Graves' disease	7.29e-05	0.000447	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—B3GNT2—Graves' disease	7.17e-05	0.00044	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—IL2RA—Graves' disease	6.98e-05	0.000428	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—IL2RA—Graves' disease	6.43e-05	0.000395	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—IL2RA—Graves' disease	6.33e-05	0.000388	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—IL2RA—Graves' disease	6.31e-05	0.000387	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—IL2RA—Graves' disease	6.2e-05	0.00038	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—IL2RA—Graves' disease	5.76e-05	0.000353	CbGpPWpGaD
